-
Value of Multi-Indication Immunotherapies for the Treatment of Autoimmune Diseases in the United States (US)
Mar 10, 2025, 14:00 PM -
Retrospective Analysis of Cannabis Hyperemesis Syndrome (CHS) Using US Electronic Medical Records: Demographics and Clinical Characteristics
Mar 10, 2025, 14:00 PM -
Wider Societal Impact of Reducing Prevalence of Obesity: A Comparison of US and UK Impact Frameworks
Mar 10, 2025, 14:00 PM -
Cost-Effectiveness Analysis of Screening for Cervical Lesion and Diagnosis and Treatment of Cervical Cancer In Nigeria
Mar 10, 2025, 14:00 PM -
Patient, Caregiver, and Physician Perspectives on the Burden of Disease Chronic Refractory Gout and Its Treatment: Concept Elicitation
Mar 10, 2025, 14:00 PM -
Evolution of Technology Diffusion within Brazilian Universal Healthcare System (Sistema Único de Saúde - SUS) 2+ Years After Listing of Antiangiogenics Treatment for Age-Related Macular Edema (AMD)
Mar 10, 2025, 14:00 PM -
Estimating the Impact of Pill Burden on the Utility of Patients Undergoing Hemodialysis
Mar 10, 2025, 14:00 PM -
Real-World Economic and Clinical Burden of Worsening Heart Failure in the US: Administrative Claims Database Analysis
Mar 10, 2025, 14:00 PM -
Real World Treatment Patterns, Genetic Testing, and Clinical Outcomes among Patients with mCRPC Treated with Olaparib Monotherapy in US Urology Clinics
Mar 10, 2025, 14:00 PM -
Use of Patient Support Program Data for Real-World Evidence Generation: Opportunities and Pitfalls Illustrated in a Case Study Assessing Trastuzumab Deruxtecan Among Patients With Breast Cancer
Mar 10, 2025, 14:00 PM -
Economic Evaluation of Detection, Treatment, and Prevention Interventions for Perinatal Mood and Anxiety Disorders: A Systematic Literature Review
Mar 10, 2025, 14:00 PM -
Effectiveness of Digital Care Platforms for Cancer Patients: A Systematic Review and Meta-Analysis
Mar 10, 2025, 14:00 PM -
Hospital Budget Impact Model of Patterned Frequency-Modulated Oral Stimulation in Preterm Infants
Mar 10, 2025, 14:00 PM -
Budget Impact Analysis of Venetoclax Combination Therapies for the Treatment of Newly Diagnosed Acute Myeloid Leukemia Patients Who Are Aged 75 Years or Older, or Who Have Comorbidities That Preclude Use of Intensive Induction Chemotherapy
Mar 10, 2025, 14:00 PM -
The Clinical Value and Cost-Effectiveness of DefenCath for Reducing Catheter-Related Bloodstream Infections in Adult Patients Receiving Hemodialysis Through a Central Venous Catheter
Mar 10, 2025, 14:00 PM -
Do Framing and Attribute Number Influence Choice Consistency in a Preference-Based Value Assessment of Equity and Efficiency?
Mar 10, 2025, 14:00 PM
